( 02171.hk)
市盈率-5.25市净率2.49市销率589.18股息率0.00%上市时间2021-06-18股价7.02港币 (-2.77% , 6,983.38万港币) 市值40.12亿港币总股本5.72亿上市至今年化投资收益率-34.54%港股通持仓占H股比例26.63%累计做空占H股本比2.13%
所属三级行业生物技术 (恒生) 市盈率-49.59市净率2.75市销率5.16股息率0.63%
所属指数指数纳入纳出
备注 (2): 双击编辑备注
发表讨论

科济药业-B(02171) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1趙向可Independent Non Executive Director - A/F2023-07-04--
2李華兵Independent Non Executive Director2023-03-09--
3蔣華Executive Director2022-08-01--
4顏光美Independent Non Executive Director2021-06-18--
5蘇德揚Independent Non Executive Director - A/F2021-06-182023-06-30
6樊春海Independent Non Executive Director2021-06-182023-01-11
7郭華清Non Executive Director2020-09-18--
8謝榕剛Non Executive Director2020-09-18--
9郭炳森Non Executive Director2018-09-13--
10王華茂Executive Director2018-09-13--
11趙雅超Non Executive Director2018-09-132022-05-27
12李宗海Executive Director2018-02-09--